Mycotoxic and aristolochic acid theories of the development of endemic nephropathy

Arhiv za Higijenu Rada i Toksikologiju

Volumn 59, Issue 1, 2008, Pages 59-65

  Peraica, Maja ^a   Domijan, Ana Marija ^a   Šarić, Marko ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Chinese herbs nephropathy; DNA adducts; Kidney tumours; Mycotoxins; Ochratoxin A; p53

Indexed keywords

ARISTOLOCHIC ACID; OCHRATOXIN; PROTEIN P53;

BLOOD SAMPLING; CARCINOGENESIS; CHINESE HERB; CLINICAL FEATURE; DISEASE COURSE; DNA ADDUCT; GENE MUTATION; HISTOLOGY; HUMAN; KIDNEY DISEASE; REVIEW; RURAL POPULATION;

ARISTOLOCHIC ACIDS; BALKAN NEPHROPATHY; HUMANS; OCHRATOXINS;

EID: 42149179228     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-59-2008-1865     Document Type: Review

References (44)

1. Cosyns JP. Aristolochic acid and "Chinese herbs nephropathy". Drug Safety 2003;26:33-48.
2. Čeović S, Pleština R, Miletić-Medved M, Stavljenić A, Mitar J, Vukelić M. Epidemiological aspects of Balkan endemic nephropathy in typical focus in Yugoslavia. In: Castegnaro M, Pleština R, Dirheimer G, Chernozemsky IN, Bartsch H, editors. Mycotoxins, endemic nephropaty and urinary tract tumours. Lyon: International Agency for Research on Cancer; 1991. p. 5-10.
3. Miletić-Medved M, Domijan A-M, Peraica M. Recent data on endemic nephropathy and related urinary tumors. Wien Klin Wochenschr 2005;117:604-9.
4. Miletić-Medved M, Jelaković B, Bistrović D, Leko N, Marić Z. Epidemiološke osobitosti endemske nefropatije u Hrvatskoj 2005. godine [Epidemiological characteristics of endemic nephropathy in Croatia in 2005, in Croatian]. Acta Med Croat 2007;61:141-8.
5. Maaroufi K, Achour A, Hammami M, El May M, Betbeder AM, Ellouz F, Creppy EE, Bacha H. Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol 1995;14:609-15.
6. Wafa EW, Yahya RS, Sobh MA, Eraky I, El-Baz M, El-Gayar HAM, Betbeder AM, Creppy EE. Human ochratoxicosis and nephropathy in Egypt: A preliminary study. Hum Exp Toxicol 1998;17:124-9.
7. Grosso F, Said S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S. New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal disease in Tunisia. Food Chem Toxicol 2003;41:1133-40.
8. Breitholtz-Emunelsson A, Minervini F, Hult K, Visconti A. Ochratoxin A in human serum samples collected in Southern Italy from healthy individuals and individuals suffering from different kidney disorders. Nat Toxins 1994;2:366-70.
9. Batuman V. Fifty years of Balkan Endemic nephropathy: daunting questions, elusive answers. Kindey Int 2006;69:644-6.
10. Vanherweghem JL, Depierreux M, Tielmans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R, Vanhaelen M. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 1993;341:387-91.
11. Vanherweghem JL. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 1998;4:9-13.
12. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002;17:265-77.
13. Ćukuranović R, Ignjatović M, Stefanović V. Urinary tract tumours and Balkan nephropathy in the south Morava river basin. Kidney Int 1991;40(Suppl. 34):80S-4S.
14. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999;33:1011-7.
15. Pavlović M, Pleština R, Krogh P. Ochratoxin A contamination of foodstuffs in an area with Balkan (endemic) nephropathy. Acta Pathol Microbiol Scand Sect B 1979;87:243-6.
16. Hult K, Pleština R, Habazin-Novak V, Radić B, Čeović S. Ochratoxina A in human blood and Balkan endemic nephropathy. Arch Toxicol 1982;51:313-21.
17. Radić B, Fuchs R, Peraica M, Lucić A. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol Lett 1997;91:105-9.
18. Peraica M, Domijan AM, Matašin M, Lucić A, Radić B, Delaš F, Horvat M, Bosanac I, Balija M, Grgičević D. Variations of ochratoxin A concentration in the blood of healthy population in some Croatian cities. Arch Toxicol 2001;75:410-4.
19. Petkova-Bocharova T, Castegnaro M. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. In: Castegnaro M, Pleština R, Dirheimer G, Chernozemsky IN, Bartsch H, editors. Mycotoxins, endemic nephropathy and urinary tract tumours. Lyon: International Agency for Research on Cancer; 1991. p. 135-43.
20. Speijers GJA, Van Egmond HP. Worldwide ochratoxin A levels in food and feeds. In: Creppy EE, Castegnaro M, Dirheimer G, editors. Human ochratoxicosis and its pathologies. Montrouge: John Libbey Eurotext Ltd., INSERM; 1993. p. 85-100.
21. Peraica M, Domijan A-M, Fuchs R, Lucić A, Radić B. The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett 1999;110:105-12.
22. Petzinger E, Ziegler K. Ochratoxin A from a toxicological perspective. J Vet Pharmacol Therap 2000;23:91-8.
23. Ribar S, Mesarić M, Bauman M. High-performance liquid chromatographic determination of sphinganine and sphingosine in serum and urine of subjects from an endemic nephropathy area in Croatia. J Chromatogr B 2001;754:511-9.
24. Stoev SD, Stefanov M, Denev ST, Radi} B, Domijan A-M, Peraica M. Experimental mycotoxicosis in chickens induced by ochratoxin A and penicillic acid and intervention with natural plant extracts. Vet Res Commun 2004;28:727-46.
25. Domijan A-M, Želježić D, Kopjar N, Peraica M. Standard and Fpg-modified comet assay in kidney cells of ochratoxin A- and fumonisin B1- treated rats. Toxicology 2006;222:53-9.
26. Šegvić Klarić M, Pepeljnjak S, Domijan A-M, Petrik J. Lipid peroxidation and glutathione levels in porcine kidney PK15 cells after individual and combined treatment with fumonisin B1, beauvericin and ochratoxin A. Basic Clin Pharmacol Toxicol 2007;100:157-64.
27. Hranjec T, Kovač A, Kos J, Mao W, Chen JJ, Grollman AP, Jelaković B. Endemic nephropathy: the case for chronic poisoning by Aristolochia. Croat Med J 2005;46:116-25.
28. Long DT, Voice TC. Role of the exposure analysis in solving the mystery of Balkan endemic nephropathy. Croat Med J 2007;48:300-11.
29. Voice TC, Long DT, Radovanovi} Z, Atkins JL, McElmurry S, Niagolova N, Dimitrov P, Petropolous EA, Ganev V. Critical evaluation of environmental exposure agents suspected in the etiology of Balkan endemic nephropathy. Int J Occup Environ Health 2006;12:369-76.
30. Radonić M, Radošević Z, Županić V. Endemic nephropathy in Yugoslavia. In: International Academy of Pathology, Monograph No. 6. The Kidney. Baltimore (USA): Williams and Wilkins Co.; 1966. p. 503-22.
31. Pleština R. Some features of Balkan endemic nephropathy. Food Chem Toxicol 1992;30:177-81.
32. Vanherweghem JL, Abramowicz D, Tielmans C, Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis; a pilot study in Chinese herbs nephropathy. Am J Kidney Dis 1996;27:209-15.
33. Pfohl-Leszkowicz A, Chakor K, Creppy EE, Dirheimer G. DNA adduct formation in mice treated with ochratoxin A. IARC Sci Publ 1991;115:245-53.
34. Pfohl-Leszkowicz A, Grosse Y, Kane A, Creppy EE, Dirheimer G. Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat Res 1993;289:265-73.
35. Schmeisser HH, Schoepe KB, Wiessler M. DNA adduct formation of aristolochic acid I and II in vitro and in vivo. Carcinogenesis 1988;9:297-303.
36. Gautier J-C, Richoz J, Welti H, Markovic J, Gremaud E, Guengerich FP, Turesky RJ. Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes. Chem Res Toxicol 2001;14:34-45.
37. Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H, Völker W, Dekant W. Ochratoxin A: lack of formation of covalent DNA adducts. Chem Res Toxicol 2004;17:234-42.
38. Arlt VM, Ferlulga D, Stiborova M, Pfohl-Leszkowica, Vukelić M, Čeović S, Schmeiser HH, Cosyns JP. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 2002;101:500-2.
39. Pfohl-Leszkowicz A, Grosse Y, Castegnaro M, Petkova-Bocharova T, Nicolov IG, Chernozemsky IV, Bartsch H, Betbeder AM, Creppy EE, Dirheimer G. Similarity between ochratoxin A induced DNA adducts in mice and DNA adducts in urinary tract tumours in humans with Balkan endemic nephropathy. In: Scudamore K, editor. Occurrence and significance of mycotoxins. London: Central Science Laboratory; 1994. p. 239-43.
40. Nortier JL, Munitz Martinez MC, Schmeiser HH, Arlt VM, Bieler CH, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL. Urothelial carcinoma associated with the use of Chinese herb (Aristolochia fangchi). New Engl J Med 2000;342:1686-92.
41. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. New molecular and field evidence for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Molec Nutr Food Res 2007;51:1131-46.
42. Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, Moll U, Suzuki N, Fernandes A, Tosenquist T, Medverec Z, Jakovina K, Brdar B, Slade N, Turesky RJ, Goodenough AK, Rieger R, Vukelić M, Jelaković B. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. PNAS 2007;104:12129-34.
43. Schmeiser HH. Chemical and molecular basis of the toxicity of Aristolochia and plants containing pyrrolizidine alkoids. Toxicology 2007;240:147.
44. Krasteva ME, Georgieva EI. Germline p53 single-base changes associated with Balkan endemic nephropathy. Biochem Biophys Res Commun 2006;342:562-7.